星空传媒91传媒制片厂|明星换脸五级片|麻豆传媒映画女演员王茜|麻豆在传媒在线|九九国产|91制片厂在线观看一二区|夜夜草视频|四虎影院在线播放|国产精品亚洲国际在线看|大象传媒国产第一页,麻豆映画传媒有免费的吗,91制片厂安卓,亚洲成年人精选,91你懂得国产,爱豆视传媒短视频免费,免费一级片

Page Options
>> >>view
Enterprises volunteer as 'investment promotion ambassadors'
2024-11-08


1108-4.jpeg



"I strongly recommend Zhongshan to all Shanghai-based enterprises present here today, especially those who want to tap into the Greater Bay Area market."


Zhang Shaodian, CEO and founder of Shanghai-based company SYNYI AI, delivered a speech at the 2024 Zhongshan Business Environment Promotion Conference on November 5 as a representative of enterprises in the Yangtze River Delta region that had settled projects in Zhongshan, volunteering as an "investment promotion ambassador" of Zhongshan.


SYNYI AI is a quasi-unicorn company in the medical field founded by overseas returned scientists. It made the list of Forbes AI 50 in China. Headquartered in Shanghai, the company entered the Greater Bay Area market five years ago.


"On June 28 this year, Guangdong SYNYI was registered, only 99 days since my first official visit to Zhongshan. And less than half a year, SYNYI AI's South China center officially opened... This all showcases the incredible 'Zhongshan speed'." Zhang Shaodian explained the reason he chose to settle the company in Zhongshan.


"From the bottom of my heart, I invite everyone to do business and pursue development in Zhongshan," said Zhang Shaodian, adding that he hopes Zhongshan will have a better future and more enterprises, especially technology-based ones, will seek development in Zhongshan.


Ma Zhenkun, founder and CEO of TenNor Therapeutics, a company that is based in Suzhou and also settles its project in Zhongshan, recommended Zhongshan during the conference as well.


TenNor Therapeutics is a company dedicated to developing first-in-class new drugs in the field of bacterial infections and bacterial metabolic diseases. On May 24 this year, TenNor Therapeutics signed an investment agreement with the Zhongshan Cuiheng Jianhui Industrial Park, planning to invest 300 million yuan in building industrial headquarters.


"I believe TenNor Therapeutics can take root and develop in Zhongshan, a fertile land for the biomedical industry, and go global in the future," said Ma Zhenkun, adding that Zhongshan attaches great importance to the biomedical industry and provides strong support in terms of policy, talent introduction and innovation environment building.

Close】 【Print
ICP?Registration?Number:?粵ICP備?11005604號
Police?Registration?Number:?44200002442868
Website?ID:?4420000052
Sponsored?by:??Office?of?Zhongshan?Municipal?People's?Government
Technical?Support:???Information?Center?of?Zhongshan
Without?written?authorization?from??Zhongshan?Municipal?People’s?Government,?the?content?of?the?site?shall?not?be?republished?or?used?in?any?form.
About Us | Site Map| Privacy Statement| Contact us